Evaluation and Characteristics of a New Direct Compression Performance Excipient - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Evaluation and Characteristics of a New Direct Compression Performance Excipient
The authors investigated the tableting properties of PanExcea MHC300G, a high-performance excipient.


Pharmaceutical Technology
Volume 35, Issue 3

References

1. D. McCormik, Pharm. Technol. 5, (4) 52–62 (2005) .

2. N.A. Armstrong, Encyclopedia of Pharmaceutical Technology, Informa Healthcare USA, Inc. (New York, Third Edition, 2006).

3. H.G. Kristensen and T. Schaefer, Drug Dev. and Ind. Pharm. 13, 803–872 (1987).

4. A.J. Hlinak, et al., J. of Pharm. Innov. 1, 12–17 (2006).

5. M. Jivraj, L.G. Martini, C.M. Thomson, Pharm. Sci. and Technol. Today, 3, 58–63 (2000).

6. R.J. Roberts, R.C. Rowe, Int. J. of Pharm. 36, 205–209 (1987).

7. K. van der Voort Maarschalk, G.K. Bolhuis, Pharm. Technol. 23, 34–46 (1999).

8. K. van der Voort Maarschalk et al., Int. J. of Pharm. 151, 27–34 (1997).

9. G.K. Bolhuis, N.A. Armstrong, Pharm. Dev. and Technol. 11, 111–124 (2006).

10. G. Bubb, Tablets and Capsules, 7, (2007).

11. IPEC–Americas, Frequently Asked Questions web page, http://ipecamericas.org/about/faqs/, accessed Feb. 16, 2011.

12. N. Deorkar, Tablets and Capsules, 8, 22–26 (2008).

13. L. Mīinea, J. Farina, M. Kallam, N. Deorkar, Pharm. Processing, Feb. 2009, http://www.pharmpro.com/Articles/2009/03/A-New-World-of-Excipients-for-Oral-Solid-Dosage-Formulation/, accessed Feb. 16, 2011.

14. S.K. Nachaegari, A.K. Bansal, Pharm. Technol. 28 (1) 52–64 (2004).

15. M.C. Gohel, P.D. Jogani, J. of Pharm. and Pharm. Sci. 8, 76–93 (2005).

16. C. Moreton, "Functionality and Performance of Excipients in a Quality-by-Design World: Parts 1–6," a series of papers published in each issue of vol. 12 of American Pharmaceutical Review (2009).

17. N. Deorkar, J. Farina, L. Mīinea, S. Randive, "Directly Compressible High Functionality Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof" PCT/US2008/011555 (Oct. 2008).

18. Mallinckrodt Baker, product profile for PanExcea MHC300G, http://www.mallbaker.com/Literature/Documents/PanExcea%20IR%20Product%20Profile%20Lit7001.pdf, accessed Feb. 16, 2011.

19. L. Mīinea, R. Mehta, J. Farina, N. Deorkar, "Granular Excipients Based on Microcrystalline Cellulose: DOE study of a lab-based scale high shear granulation process," poster presentation at "Excipient Fest Americas", (Puerto Rico, April 2008).

20. USP 34–NF 29 General Chapter <1174> "Powder Flow."

21. Carr, R. L. Chem. Eng. 72,163–168, 1965.

22. Hosokawa Micron, product profile for Hosokawa Micron Powder Characteristics Tester PT-S, http://www.hosokawa.co.uk/powdtest.php, accessed Feb. 16, 2011.

23. S.I.F. Badawy, D.B. Gray, M.A. Hussain, Pharm. Res. 23, 634–640 (2006).

24. T. Suzuki et al., J. of Pharm. and Pharmacol. 53, 609–616 (2001).

25. C.K. Tye, C. Sun, G.E. Amidon, J. of Pharm. Sci. 94, 465–472 (2005).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here